Skip to content
2000
Volume 21, Issue 6
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Several novel antipsychotics have been outlined in this review. Different synthetic methods for the synthesis of promising antipsychotics have been summarized. There are different starting materials from which we can start to prepare the proposed antipsychotics. Also, the final nucleus of the proposed antipsychotics is different . 8-azabicyclo[3.2.1]oct-3β-yl-amide 8a-w, 3-aminoethyl tetralones 19, 3-fluourobenzoyl-propionic acid 22, 6,7-dihydrobenzo[b]thiophen-4(5H)-one derivative 26, 3,4-dihydronaphthalen-1(2H)-one derivative 30, Benzocycloalkanone derivative 36, 3-methyl-6,7-dihydrobenzo[d]isoxazol-4(5H)-one derivative 55, 1,5,6,7-tetrahydro-4H-indazol-4-one derivative 61, 2-methyl-1,5,6,7-tetrahydro-4H-benzo[d]imidazol-4-one derivative 66. Different antipsychotic activities of the prepared compounds are summarized.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072304305240802093232
2024-08-16
2025-10-29
Loading full text...

Full text loading...

References

  1. AlvaradoM. BarcelóM. CarroL. MasaguerC.F. RaviñaE. Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics.Chem. Biodivers.20063110611710.1002/cbdv.200690001 17193223
    [Google Scholar]
  2. JainM.S. SuranaS.J. Synthesis and evaluation of antipsychotic activity of 11-(4′-(N-aryl carboxamido/N-aryl-α-phenyl-acetamido)-] piperazinyl)-dibenz[b,f][1,4]-oxazepine derivatives.Arab. J. Chem.201710S2032S203910.1016/j.arabjc.2013.07.033
    [Google Scholar]
  3. YousifM.N.M. FathyU. YousifN.M. Synthesis and anticancer activity of novel chromene derivatives, chromeno[2,3-d][1,3]] oxazines, and chromeno[2,3-d]pyrimidines.Med. Chem.202319657858510.2174/1573406419666221226094133 36573048
    [Google Scholar]
  4. YousifM.N.M. AbdelhameedR.M. Abu-HashemA.A. YousifN.M. Synthesis and biological activity of chromene derivatives, chromeno[2,3-d][1,3]oxazine derivatives, and chromeno[2,3-d]pyrimidine derivatives.Egypt. J. Chem.202366111312010.21608/ejchem.2022.114873.5214
    [Google Scholar]
  5. FathyU. YousifM. Mohi El-DeenE. FayedE. Design, Synthesis, and biological evaluation of a novel series of thiazole derivatives based on pyrazoline as anticancer agents.Egypt. J. Chem.2022651321241125210.21608/ejchem.2022.157866.6848
    [Google Scholar]
  6. YousifM. El-GazzarA.R. HafezH. YousifN. Synthesis] and biological evaluation of novel quinazoline, chromene and chromeno[2,3-d]pyrimidine derivatives.Egypt. J. Chem.2022651231932510.21608/ejchem.2022.113647.5161
    [Google Scholar]
  7. MahmoudN.M.Y. AhmedE.R. NabilM.Y. New and facile synthesis of 2-Chloro-1,3-diketones.Int. J. Chem. Chemi. Proce.202281283310.56201/ijccp.v8.no1.2022.pg28.33
    [Google Scholar]
  8. YousifM.N.M. Recent advances in chemistry and biological activity of 2,6-diphenyl piperidines.Mini Rev. Org. Chem.202219112513510.2174/1570193X18666210224153249
    [Google Scholar]
  9. MohamedH.A. Abdel-WahabB.F. YousifM.N.M. AbdelhameedR.M. Novel allyl-hydrazones including 2,4-dinitrophenyl and 1,2,3-triazole moieties as optical sensor for ammonia and chromium ions in water.BMC Chem.2022161263310.1186/s13065‑022‑00820‑2 35392971
    [Google Scholar]
  10. YousifM.N.M. El-GazzarA.R.B.A. HafezH.N. FayedA.A. ElRashedyA. YousifN.M. Recent advances in the chemistry and biological activity of sulfonamide derivatives.Mini Rev. Org. Chem.202219669570710.2174/1570193X19666220105145504
    [Google Scholar]
  11. RahmanA.A.H.A. ShabanA.K.F. NassarI.F. YousifM.N.M. El-KadyD.S. AwadH.M. El-SayedW.A. Synthesis and anticancer activity of new pyrimidine and oxadiazole acyclic nucleoside analogs and thiazolopyrimidine derivatives.Russ. J. Gen. Chem.202191102086209410.1134/S1070363221100261
    [Google Scholar]
  12. YousifM.N.M. YousifN.M. Synthesis and biological activity of cycloocta[b]pyridine derivatives.Pharma Chem.202113101015
    [Google Scholar]
  13. YousifM.N.M. El-GazzarA.R.B.A. El-EnanyM.M. Synthesis and biological evaluation of pyrido(2,3-d)pyrimidines.Mini Rev. Org. Chem.2021181435410.2174/1570193X17999200511010402
    [Google Scholar]
  14. YousifM.N.M. El-GazzarA.B.A. FayedA.A. El-ManawatyM.A. YousifN.M. Synthesis and cytotoxic evaluation of novel chromenes, and chromene(2,3-d)pyrimidines.J. Appl. Pharm. Sci.20201012354310.7324/JAPS.2020.101205
    [Google Scholar]
  15. YousifM.N.M. SolimanH.A. SaidM.M. HassanN.A. Abdel-MegeidF.M.E. Synthesis and biological activity of triacetonamine.Russ. J. Gen. Chem.202090346046910.1134/S1070363220030202
    [Google Scholar]
  16. YousifM.N.M. SolimanH.A. SaidM.M. HassanN.A. Abdel-MegeidF.M.E. Erratum to: Synthesis and biological activity of triacetonamine.Russ. J. Gen. Chem.202090476710.1134/S1070363220040350
    [Google Scholar]
  17. FayedA.A. AlahmadiY.M. YousifM.N.M. YousifN.M. AmerA.A. El-FarargyA.F. OufN.H. GadF.A. Synthesis and anti-inflammatory activity of some new pyrimidinothienocinnoline derivatives.Russ. J. Gen. Chem.20198991887189510.1134/S1070363219090251
    [Google Scholar]
  18. YousifM.N.M. NassarI.F. YousifN.M. AwadH.M. El-SayedW.A. Synthesis and anticancer activity of new substituted piperidone compounds and their derived pyrimidine, thiazole and triazole glycoside derivatives.Russ. J. Gen. Chem.20198981673168210.1134/S1070363219080218
    [Google Scholar]
  19. FayedA.A. YousifM.N.M. AbdelgawadT.T. AmrA.E.G.E. YousifN.M. GadF.A. Synthesis and antimicrobial activity of novel polycyclic thienopyridazine derivatives.Chem. Heterocycl. Compd.201955877377810.1007/s10593‑019‑02534‑1
    [Google Scholar]
  20. NemrM.T.M. YousifM.N.M. BarciszewskiJ. Interaction of small molecules with polynucleotide repeats and frameshift site RNA.Arch. Pharm. (Weinheim)20193528190006210.1002/ardp.201900062 31169327
    [Google Scholar]
  21. YousifM.N.M. FayedA.A. YousifN.M. Synthesis and reactions of N-hydroxy-triacetonamine derivatives.Egypt. J. Chem.20196281759176610.21608/ejchem.2019.7103.1586
    [Google Scholar]
  22. FayedA.A. BahashwanS.A. YousifM.N.M. ShafeyH.M.E. AmrA.E. YousifN.M. ShadidK.A. Synthesis and antiproliferative activity of some newly synthesized pyrazolopyridine derivatives.Russ. J. Gen. Chem.20198961209121710.1134/S1070363219060173
    [Google Scholar]
  23. YousifM.N.M. HusseinH.A.R. YousifN.M. El-ManawatyM.A. El-SayedW.A. Synthesis and anticancer activity of novel 2-phenylindole linked imidazolothiazole, thiazolo-s-triazine and imidazolyl-sugar systems.J. Appl. Pharm. Sci.20199161410.7324/JAPS.2019.90102
    [Google Scholar]
  24. YousifM.N.M. FayedA.A. YousifN.M. Reactions of triacetonamine part ii, synthesis of novel pyrazolo(4,3-c)pyridine derivatives, and 2-(piperidin-4-ylidene)hydrazinecarbothioamide derivatives derived from 2,2,6,6-tetramethyl-piperidin-4-one for in vitro anticancer evaluation.Pharma Chem.2018108105109
    [Google Scholar]
  25. YousifM.N.M. El-SayedW.A. AbbasH.S. AwadH.M. YousifN.M. Anticancer activity of new substituted pyrimidines, their thioglycosides and thiazolopyrimidine derivatives.J. Appl. Pharm. Sci.2017711213210.7324/JAPS.2017.71104
    [Google Scholar]
  26. SolimanH.A. YousifM.N.M. SaidM.M. HassanN.A. AliM.M. AwadH.M. Abdel-MegeidF.M.E. Synthesis of novel 1,6-naphthyridines, pyrano[3,2-c]pyridines and pyrido[4,3-d]pyrimidines derived from 2,2,6,6-tetramethylpiperidin-4-one for in vitro anticancer and antioxidant evaluation.Pharma Chem.201463394410
    [Google Scholar]
  27. El-GazzarA.R.B.A. El-EnanyM.M. MahmoudM.N. Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones.Bioorg. Med. Chem.20081663261327310.1016/j.bmc.2007.12.012 18158248
    [Google Scholar]
  28. StefanowiczJ. SłowińskiT. WróbelM.Z. ŚlifirskiG. DawidowskiM. StefanowiczZ. Jastrzębska-WięsekM. PartykaA. WesołowskaA. TurłoJ. Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile.Med. Chem. Res.20182781906192810.1007/s00044‑018‑2203‑z 30100693
    [Google Scholar]
  29. RaviñaE. MasaguerC.F. Conformationally constrained butyrophenones. Synthesis and evaluation as antipsychotics.Curr. Med. Chem.200114362
    [Google Scholar]
  30. BarcelóM. RaviñaE. VarelaM.J. BreaJ. LozaM.I. MasaguerC.F. Potential atypical antipsychotics: Synthesis, binding affinity and SAR of new heterocyclic bioisosteric butyrophenone analogues as multitarget ligands.MedChemComm20112121194120010.1039/c1md00202c
    [Google Scholar]
  31. CapuanoB. CrosbyI.T. LloydE.J. PodlouckaA. TaylorD.A. Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogue of clozapine II. Effect of the nature and length of the linker.Aust. J. Chem.200356987588610.1071/CH03030
    [Google Scholar]
  32. SmitsR.A. LimH.D. SteginkB. BakkerR.A. de EschI.J.P. LeursR. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.J. Med. Chem.200649154512451610.1021/jm051008s 16854056
    [Google Scholar]
  33. WaghB.S. PatilB.P. JainM.S. HarakS.S. WaghS.B. Synthesis and evaluation of antipsychotic activity of 11-(4-aryl-1-piperazinyl)-dibenz [b,f][1,4] oxazepines and their 8-chloro analogues.Heterocycl. Commun.2007132-316517210.1515/HC.2007.13.2‑3.165
    [Google Scholar]
  34. WaghS.B. PatilB.P. YerandeS.W. Synthesis and evaluation of antipsychotic activity of 8-chloro-11-(4-aryl-1-piperazinyl)-dibenz [b,f][1,4] oxazepines.Indian Patent365/MUM/05,2005
    [Google Scholar]
  35. ChenY. XuX. LiuX. YuM. LiuB.F. ZhangG. Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.PLoS One201274e3518610.1371/journal.pone.0035186 22558126
    [Google Scholar]
  36. GaoL. HaoC. MaR. ChenJ. ZhangG. ChenY. Synthesis and biological evaluation of a new class of multi-target heterocycle piperazine derivatives as potential antipsychotics.RSC Advances20211128169311694110.1039/D1RA02426D 35479681
    [Google Scholar]
  37. KahnR.S. SommerI.E. MurrayR.M. Meyer-LindenbergA. WeinbergerD.R. CannonT.D. O’DonovanM. CorrellC.U. KaneJ.M. van OsJ. InselT.R. Schizophrenia.Nat. Rev. Dis. Primers2015111506710.1038/nrdp.2015.67 27189524
    [Google Scholar]
  38. AranaG.W. An overview of side effects caused by typical antipsychotics.J. Clin. Psychiatry200061Suppl. 8511 10811237
    [Google Scholar]
  39. SerrettiA. RonchiD. LorenziC. BerardiD. New antipsychotics and schizophrenia: A review on efficacy and side effects.Curr. Med. Chem.200411334335810.2174/0929867043456043 14965236
    [Google Scholar]
  40. ÖgrenS.O. ErikssonT.M. Elvander-TottieE. D’AddarioC. EkströmJ.C. SvenningssonP. MeisterB. KehrJ. StiedlO. The role of 5-HT1A receptors in learning and memory.Behav. Brain Res.20081951547710.1016/j.bbr.2008.02.023 18394726
    [Google Scholar]
  41. MillanM.J. Improving the treatment of schizophrenia: Focus on serotonin (5-HT)(1A) receptors.J. Pharmacol. Exp. Ther.20002953853861 11082417
    [Google Scholar]
  42. ZhangG. StackmanR.W.Jr The role of serotonin 5-HT2A receptors in memory and cognition.Front. Pharmacol.2015622510.3389/fphar.2015.00225 26500553
    [Google Scholar]
  43. MeltzerH.Y. MasseyB.W. The role of serotonin receptors in the action of atypical antipsychotic drugs.Curr. Opin. Pharmacol.2011111596710.1016/j.coph.2011.02.007 21420906
    [Google Scholar]
  44. WuC. WangY. YangF. ShiW. WangZ. HeL. HeY. ShenJ. Synthesis and biological evaluation of five‐atom‐linker‐based arylpiperazine derivatives with an atypical antipsychotic profile.ChemMedChem201914242042205110.1002/cmdc.201900439 31746558
    [Google Scholar]
  45. GaoL. YangZ. XiongJ. HaoC. MaR. LiuX. LiuB.F. JinJ. ZhangG. ChenY. Design, synthesis and biological investigation of flavone derivatives as potential multi-receptor atypical antipsychotics.Molecules202025184107412410.3390/molecules25184107 32911828
    [Google Scholar]
  46. ChenY. WangS. XuX. LiuX. YuM. ZhaoS. LiuS. QiuY. ZhangT. LiuB.F. ZhangG. Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.J. Med. Chem.201356114671469010.1021/jm400408r 23675993
    [Google Scholar]
  47. IbrahimH.M. TammingaC.A. Schizophrenia: Treatment targets beyond monoamine systems.Annu. Rev. Pharmacol. Toxicol.201151118920910.1146/annurev.pharmtox.010909.105851 20868275
    [Google Scholar]
  48. LewineR.R.J. FoggL. MeltzerH.Y. Assessment of negative and positive symptoms in schizophrenia.Schizophr. Bull.19839336837610.1093/schbul/9.3.368 6622994
    [Google Scholar]
  49. MarderS.R. WirshingW.C. Van PuttenT. Drug treatment of schizophrenia.Schizophr. Res.199142819010.1016/0920‑9964(91)90027‑O 1674883
    [Google Scholar]
  50. BaldessariniR.J. TarsyD. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.Annu. Rev. Neurosci.198031233910.1146/annurev.ne.03.030180.000323 6106450
    [Google Scholar]
  51. BoydA.E.III ReichlinS. Neural control of prolactin secretion in man.Psychoneuroendocrinology19783211313010.1016/0306‑4530(78)90001‑X 30107
    [Google Scholar]
  52. GeddesJ. FreemantleN. HarrisonP. BebbingtonP. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis.BMJ200032172731371137610.1136/bmj.321.7273.1371 11099280
    [Google Scholar]
  53. JonesC.A. McCrearyA.C. Serotonergic approaches in the development of novel antipsychotics.Neuropharmacology20085561056106510.1016/j.neuropharm.2008.05.025 18621404
    [Google Scholar]
  54. ShapiroD.A. RenockS. ArringtonE. ChiodoL.A. LiuL.X. SibleyD.R. RothB.L. MailmanR. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.Neuropsychopharmacology20032881400141110.1038/sj.npp.1300203 12784105
    [Google Scholar]
  55. RothB. HanizavarehS.M. BlumA. Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders.Psychopharmacology (Berl.)20041741172410.1007/s00213‑003‑1683‑8 15205874
    [Google Scholar]
  56. MeltzerH.Y. LiZ. KanedaY. IchikawaJ. Serotonin receptors: Their key role in drugs to treat schizophrenia.Prog. Neuropsychopharmacol. Biol. Psychiatry20032771159117210.1016/j.pnpbp.2003.09.010 14642974
    [Google Scholar]
  57. KinonB.J. LiebermanJ.A. Mechanisms of action of atypical antipsychotic drugs: A critical analysis.Psychopharmacology (Berl.)19961241-223410.1007/BF02245602 8935797
    [Google Scholar]
  58. MöllerH.J. Management of the negative symptoms of schizophrenia: New treatment options.CNS Drugs2003171179382310.2165/00023210‑200317110‑00003 12921492
    [Google Scholar]
  59. VohoraD. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.Curr. Opin. Investig. Drugs200787531538 17659473
    [Google Scholar]
  60. SchultzS.H. NorthS.W. ShieldsC.G. Schizophrenia: A review.Am. Fam. Physician2007751218211829 17619525
    [Google Scholar]
/content/journals/cbc/10.2174/0115734072304305240802093232
Loading
/content/journals/cbc/10.2174/0115734072304305240802093232
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test